Kumar Rakhi 4
4 · NeuroPace Inc · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
NeuroPace Director Kumar Rakhi Receives 8,258-Share Award
What Happened
- Director Kumar Rakhi received awards from NeuroPace (NPCE) on 2026-06-05 totaling 8,258 shares: 2,890 shares issued (direct award) and 5,368 shares reported as a derivative (option-type award). Both were recorded at $0.00 per share, i.e., no cash paid.
- These are compensation awards, not open-market purchases or sales.
Key Details
- Transaction date: 2026-06-05. Transaction code: A (award/grant/acquisition). Price: $0.00 for both items.
- Share counts: 2,890 ordinary shares (award) + 5,368 derivative shares (option/award) = 8,258 total.
- Vesting: Both awards vest in 12 equal consecutive monthly installments, subject to continuous service through each vesting date (footnotes F1 & F2).
- Amount owned after transaction: Not specified in the provided filing excerpt.
- Filing timeliness: Filing date equals transaction date (2026-06-05); no late filing indicated in the provided information.
Context
- The 5,368 "derivative" shares are an option-type award that will become exercisable as they vest; this is not an immediate exercise or sale.
- Director awards are common forms of compensation and do not, by themselves, indicate insider buying or selling sentiment. They primarily reflect compensation and retention practices.
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Kumar Rakhi
Director
Transactions
- Award
Common Stock
[F1]2026-06-05+2,890→ 22,050 total - Award
Stock Option (Right to Buy)
[F2]2026-06-05+5,368→ 5,368 totalExercise: $15.74Exp: 2036-06-04→ Common Stock (5,368 underlying)
Footnotes (2)
- [F1]The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.
- [F2]The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.
Signature
/s/ Leah Akin, Attorney-in-Fact|2026-06-05